AngioDynamics to Present at Adams Harkness' 24th Annual Summer Seminar on August 3, 2004
Adams Harkness's Annual Summer Seminar is one of the industry's longest-running conferences focusing exclusively on the growth markets. The conference will feature 200 public and private companies from the technology, healthcare, and consumer industries along with midyear updates on corporate strategies and other investment issues.
Individuals may listen to a live webcast of the presentation by logging on to the Investor Relations section of AngioDynamics' web site http://investor.angiodynamics.com/ a few minutes prior to start time to download any necessary software. The presentation will be archived for 30 days.
About AngioDynamics
AngioDynamics, Inc. designs, develops, manufactures and markets innovative medical devices used in minimally invasive, image-guided procedures to treat peripheral vascular disease. It offers a broad line of therapeutic and diagnostic devices that enable interventional physicians, such as interventional radiologists, vascular surgeons and others, to treat peripheral vascular diseases and other non-coronary diseases. AngioDynamics' diversified product line includes angiographic catheters, hemodialysis catheters, PTA dilation catheters, thrombolytic products, image-guided vascular access products, endovascular laser venous system products, as well as drainage products. AngioDynamics is a majority-owned subsidiary of E-Z-EM, Inc. (AMEX:EZM), a leading manufacturer of contrast agents for gastrointestinal radiology.
CONTACT: AngioDynamics, Inc.
Lisa Donegan, (800) 772-6446 x370
www.AngioDynamics.com
or
Investor Relations Contacts:
Lippert/Heilshorn & Associates, Inc.
Kim Sutton Golodetz (kgolodetz@lhai.com)
Shayne Payne (spayne@lhai.com)
(212) 838-3777
Bruce Voss (bvoss@lhai.com)
(310) 691-7100
SOURCE: AngioDynamics, Inc.